198 related articles for article (PubMed ID: 17207150)
1. Quality control of active ingredients in artemisinin-derivative antimalarials within Kenya and DR Congo.
Atemnkeng MA; De Cock K; Plaizier-Vercammen J
Trop Med Int Health; 2007 Jan; 12(1):68-74. PubMed ID: 17207150
[TBL] [Abstract][Full Text] [Related]
2. Post-marketing assessment of content and efficacy of preservatives in artemisinin-derived antimalarial dry suspensions for paediatric use.
Atemnkeng MA; De Cock K; Plaizier-Vercammen J
Malar J; 2007 Jan; 6():12. PubMed ID: 17257400
[TBL] [Abstract][Full Text] [Related]
3. Paediatric formulations of artemisinin-based combination therapies for treating uncomplicated malaria in children.
Bélard S; Ramharter M; Kurth F
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD009568. PubMed ID: 33289099
[TBL] [Abstract][Full Text] [Related]
4. Substandard artemisinin-based antimalarial medicines in licensed retail pharmaceutical outlets in Ghana.
El-Duah M; Ofori-Kwakye K
J Vector Borne Dis; 2012 Sep; 49(3):131-9. PubMed ID: 23135006
[TBL] [Abstract][Full Text] [Related]
5. Clinical trials of artemisinin and its derivatives in the treatment of malaria in China.
Li GQ; Guo XB; Fu LC; Jian HX; Wang XH
Trans R Soc Trop Med Hyg; 1994 Jun; 88 Suppl 1():S5-6. PubMed ID: 8053027
[TBL] [Abstract][Full Text] [Related]
6. [Combined antimalarial therapy using artemisinin].
Majori G
Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
[TBL] [Abstract][Full Text] [Related]
7. Quality evaluation of chloroquine, quinine, sulfadoxine-pyrimethamine and proguanil formulations sold on the market in East Congo DR.
Atemnkeng MA; Chimanuka B; Plaizier-Vercammen J
J Clin Pharm Ther; 2007 Apr; 32(2):123-32. PubMed ID: 17381662
[TBL] [Abstract][Full Text] [Related]
8. A pilot study on quality of artesunate and amodiaquine tablets used in the fishing community of Tema, Ghana.
Affum AO; Lowor S; Osae SD; Dickson A; Gyan BA; Tulasi D
Malar J; 2013 Jun; 12():220. PubMed ID: 23809666
[TBL] [Abstract][Full Text] [Related]
9. Quality of antimalarial drugs and antibiotics in Papua New Guinea: a survey of the health facility supply chain.
Hetzel MW; Page-Sharp M; Bala N; Pulford J; Betuela I; Davis TM; Lavu EK
PLoS One; 2014; 9(5):e96810. PubMed ID: 24828338
[TBL] [Abstract][Full Text] [Related]
10. Comparison of artesunate-mefloquine and artemether-lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial.
Sirima SB; Ogutu B; Lusingu JPA; Mtoro A; Mrango Z; Ouedraogo A; Yaro JB; Onyango KO; Gesase S; Mnkande E; Ngocho JS; Ackermann I; Aubin F; Vanraes J; Strub N; Carn G
Lancet Infect Dis; 2016 Oct; 16(10):1123-1133. PubMed ID: 27430374
[TBL] [Abstract][Full Text] [Related]
11. Quality of artemisinin-based antimalarial drugs marketed in Nigeria.
Izevbekhai O; Adeagbo B; Olagunju A; Bolaji O
Trans R Soc Trop Med Hyg; 2017 Feb; 111(2):90-96. PubMed ID: 28460126
[TBL] [Abstract][Full Text] [Related]
12. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
[TBL] [Abstract][Full Text] [Related]
13. Quality of artemisinin-based combination formulations for malaria treatment: prevalence and risk factors for poor quality medicines in public facilities and private sector drug outlets in Enugu, Nigeria.
Kaur H; Allan EL; Mamadu I; Hall Z; Ibe O; El Sherbiny M; van Wyk A; Yeung S; Swamidoss I; Green MD; Dwivedi P; Culzoni MJ; Clarke S; Schellenberg D; Fernández FM; Onwujekwe O
PLoS One; 2015; 10(5):e0125577. PubMed ID: 26018221
[TBL] [Abstract][Full Text] [Related]
14. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
[TBL] [Abstract][Full Text] [Related]
15. Characterization of counterfeit artesunate antimalarial tablets from southeast Asia.
Hall KA; Newton PN; Green MD; De Veij M; Vandenabeele P; Pizzanelli D; Mayxay M; Dondorp A; Fernandez FM
Am J Trop Med Hyg; 2006 Nov; 75(5):804-11. PubMed ID: 17123969
[TBL] [Abstract][Full Text] [Related]
16. Validation of ELISA for quantitation of artemisinin-based antimalarial drugs.
Wang M; Cui Y; Zhou G; Yan G; Cui L; Wang B
Am J Trop Med Hyg; 2013 Dec; 89(6):1122-8. PubMed ID: 24080636
[TBL] [Abstract][Full Text] [Related]
17. Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes.
Swarthout TD; van den Broek IV; Kayembe G; Montgomery J; Pota H; Roper C
Trop Med Int Health; 2006 Oct; 11(10):1503-11. PubMed ID: 17002724
[TBL] [Abstract][Full Text] [Related]
18. Detection of Poor Quality Artemisinin-based Combination Therapy (ACT) Medicines Marketed in Benin Using Simple and Advanced Analytical Techniques.
Yemoa A; Habyalimana V; Mbinze JK; Crickboom V; Muhigirwa B; Ngoya A; Sacre PY; Gbaguidi F; Quetin-Leclercq J; Hubert P; Marini RD
Curr Drug Saf; 2017; 12(3):178-186. PubMed ID: 28625144
[TBL] [Abstract][Full Text] [Related]
19. Preparation of a novel monoclonal antibody against the antimalarial drugs, artemisinin and artesunate.
Tanaka H; Putalun W; De-Eknamkul W; Matangkasombut O; Shoyama Y
Planta Med; 2007 Aug; 73(10):1127-32. PubMed ID: 17611929
[TBL] [Abstract][Full Text] [Related]
20. A colorimetric field method to assess the authenticity of drugs sold as the antimalarial artesunate.
Green MD; Mount DL; Wirtz RA; White NJ
J Pharm Biomed Anal; 2000 Dec; 24(1):65-70. PubMed ID: 11108540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
